Skip to main content

Table 2 Telomerase expression and telomere length in association with clinical and pathological features of breast cancer

From: Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

Variable Telomerase expression P* Telomere length P*
  Low High   Short Long  
Telomere length (n = 336)    0.152    
Short 87 (54.7) 83 (46.9)     
Long 72 (45.3) 94 (53.1)     
Disease stage (n = 329)    0.487    0.788
I-II 140 (90.9) 155 (88.6)   149 (89.2) 146 (90.1)  
III-IV 14 (9.1) 20 (11.4)   18 (10.8) 16 (9.9)  
Tumor grade (n = 332)    0.292    0.300
1-2 96 (61.2) 97 (55.4)   93 (55.4) 100 (61.0)  
3 61 (38.8) 78 (44.6)   75 (44.6) 64 (39.0)  
Tumor size (n = 334)    0.035    0.648
T1 103 (65.6) 92 (52.0)   98 (58.3) 97 (58.4)  
T2 45 (28.7) 74 (41.8)   58 (34.5) 61 (36.8)  
T3 and T4 9 (5.7) 11 (6.2)   12 (7.1) 8 (4.8)  
Histological type (n = 335)    0.094    0.252
Ductal 98 (62.0) 114 (64.4)   101 (59.8) 111 (66.9)  
Lobular 31 (19.6) 25 (14.1)   35 (20.7) 21 (12.7)  
Mix 19 (12.0) 15 (8.5)   17 (9.5) 18 (10.8)  
Other 10 (6.4) 23 (13.0)   17 (10.1) 16 (9.6)  
Nodal status (n = 330)    0.618    0.191
Negative 79 (51.0) 94 (53.7)   94 (56.0) 79 (48.8)  
Positive 76 (49.0) 81 (46.3)   74 (44.0) 83 (51.2)  
ER status (n = 331)    0.782    0.884
Negative 53 (34.0) 62 (35.4)   59 (35.1) 56 (34..4)  
Positive 103 (66.0) 113 (64.6)   109 (64.9) 107 (65.6)  
PR status (n = 330)    0.352    0.181
Negative 70 (44.9) 87 (50.0)   86 (51.2) 71 (43.8)  
Positive 86 (55.1) 87 (50.0)   82 (48.8) 91 (56.2)